[widget id=”ad_unit-10″]ad_unit-10[/widget]Chantix works by reducing the smoker’s craving for nicotine by binding to receptors in the brain and reducing the symptoms of withdrawal. Chantix (varenicline) also reduces the satisfaction a smoker receives when smoking a cigarette.
Clinical trials to date have shown that Chantix is more effective than currently available oral antismoking prescription medicines. In trials, 44% of the group treated with Chantix had stopped smoking after being treated for 12 weeks, as opposed to 11% of smokers taking the placebo.
Over the same duration, it was also shown that Chantix is twice as effective as Zyban (bupropion), the other main non-nicotine drug treatment.